nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—AR—breast cancer	0.195	0.54	CbGaD
Bicalutamide—AR—Fluoxymesterone—breast cancer	0.135	0.339	CbGbCtD
Bicalutamide—CYP2D6—breast cancer	0.0892	0.248	CbGaD
Bicalutamide—CYP3A4—breast cancer	0.0765	0.212	CbGaD
Bicalutamide—CYP2C9—Anastrozole—breast cancer	0.0226	0.0566	CbGbCtD
Bicalutamide—CYP2C19—Lapatinib—breast cancer	0.0181	0.0455	CbGbCtD
Bicalutamide—CYP3A4—Exemestane—breast cancer	0.0173	0.0435	CbGbCtD
Bicalutamide—CYP2C9—Idarubicin—breast cancer	0.0171	0.0429	CbGbCtD
Bicalutamide—CYP2D6—Idarubicin—breast cancer	0.0157	0.0393	CbGbCtD
Bicalutamide—CYP3A4—Letrozole—breast cancer	0.0147	0.037	CbGbCtD
Bicalutamide—CYP3A4—Anastrozole—breast cancer	0.0131	0.0329	CbGbCtD
Bicalutamide—CYP3A4—Toremifene—breast cancer	0.012	0.0301	CbGbCtD
Bicalutamide—CYP3A4—Fulvestrant—breast cancer	0.0112	0.028	CbGbCtD
Bicalutamide—CYP3A4—Thiotepa—breast cancer	0.00996	0.025	CbGbCtD
Bicalutamide—CYP2C9—Capecitabine—breast cancer	0.00938	0.0235	CbGbCtD
Bicalutamide—CYP3A4—Ixabepilone—breast cancer	0.00911	0.0228	CbGbCtD
Bicalutamide—CYP2C19—Tamoxifen—breast cancer	0.00908	0.0228	CbGbCtD
Bicalutamide—CYP3A4—Lapatinib—breast cancer	0.00877	0.022	CbGbCtD
Bicalutamide—CYP2D6—Vinorelbine—breast cancer	0.00765	0.0192	CbGbCtD
Bicalutamide—CYP2C9—Tamoxifen—breast cancer	0.00755	0.0189	CbGbCtD
Bicalutamide—CYP2D6—Tamoxifen—breast cancer	0.0069	0.0173	CbGbCtD
Bicalutamide—CYP3A4—Raloxifene—breast cancer	0.00664	0.0167	CbGbCtD
Bicalutamide—CYP2C9—Paclitaxel—breast cancer	0.00588	0.0147	CbGbCtD
Bicalutamide—CYP2C9—Fluorouracil—breast cancer	0.00556	0.0139	CbGbCtD
Bicalutamide—CYP3A4—Vinorelbine—breast cancer	0.00486	0.0122	CbGbCtD
Bicalutamide—CYP2D6—Vinblastine—breast cancer	0.00471	0.0118	CbGbCtD
Bicalutamide—CYP3A4—Tamoxifen—breast cancer	0.00439	0.011	CbGbCtD
Bicalutamide—CYP3A4—Mitoxantrone—breast cancer	0.00428	0.0107	CbGbCtD
Bicalutamide—CYP3A4—Paclitaxel—breast cancer	0.00342	0.00856	CbGbCtD
Bicalutamide—CYP3A4—Irinotecan—breast cancer	0.00337	0.00845	CbGbCtD
Bicalutamide—CYP3A4—Vinblastine—breast cancer	0.003	0.00751	CbGbCtD
Bicalutamide—CYP2D6—Doxorubicin—breast cancer	0.0029	0.00726	CbGbCtD
Bicalutamide—CYP3A4—Docetaxel—breast cancer	0.00247	0.00619	CbGbCtD
Bicalutamide—CYP3A4—Doxorubicin—breast cancer	0.00184	0.00462	CbGbCtD
Bicalutamide—Enzalutamide—AR—breast cancer	0.0011	0.397	CrCbGaD
Bicalutamide—Enzalutamide—CYP2D6—breast cancer	0.000504	0.182	CrCbGaD
Bicalutamide—Enzalutamide—CYP3A4—breast cancer	0.000432	0.156	CrCbGaD
Bicalutamide—Enzalutamide—ALB—breast cancer	0.000377	0.136	CrCbGaD
Bicalutamide—Enzalutamide—ABCB1—breast cancer	0.00036	0.13	CrCbGaD
Bicalutamide—Dizziness—Fluorouracil—breast cancer	2.33e-05	0.000132	CcSEcCtD
Bicalutamide—Visual impairment—Epirubicin—breast cancer	2.33e-05	0.000132	CcSEcCtD
Bicalutamide—Mediastinal disorder—Methotrexate—breast cancer	2.32e-05	0.000132	CcSEcCtD
Bicalutamide—Rash—Mitoxantrone—breast cancer	2.32e-05	0.000131	CcSEcCtD
Bicalutamide—Rash—Irinotecan—breast cancer	2.32e-05	0.000131	CcSEcCtD
Bicalutamide—Dermatitis—Irinotecan—breast cancer	2.32e-05	0.000131	CcSEcCtD
Bicalutamide—Dermatitis—Mitoxantrone—breast cancer	2.32e-05	0.000131	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Docetaxel—breast cancer	2.32e-05	0.000131	CcSEcCtD
Bicalutamide—Chills—Methotrexate—breast cancer	2.31e-05	0.000131	CcSEcCtD
Bicalutamide—Headache—Mitoxantrone—breast cancer	2.3e-05	0.000131	CcSEcCtD
Bicalutamide—Headache—Irinotecan—breast cancer	2.3e-05	0.000131	CcSEcCtD
Bicalutamide—Insomnia—Docetaxel—breast cancer	2.3e-05	0.00013	CcSEcCtD
Bicalutamide—Paraesthesia—Docetaxel—breast cancer	2.28e-05	0.000129	CcSEcCtD
Bicalutamide—Alopecia—Methotrexate—breast cancer	2.28e-05	0.000129	CcSEcCtD
Bicalutamide—Vomiting—Gemcitabine—breast cancer	2.28e-05	0.000129	CcSEcCtD
Bicalutamide—Bradycardia—Doxorubicin—breast cancer	2.27e-05	0.000129	CcSEcCtD
Bicalutamide—Dyspnoea—Docetaxel—breast cancer	2.27e-05	0.000128	CcSEcCtD
Bicalutamide—Somnolence—Docetaxel—breast cancer	2.26e-05	0.000128	CcSEcCtD
Bicalutamide—Mental disorder—Methotrexate—breast cancer	2.26e-05	0.000128	CcSEcCtD
Bicalutamide—Rash—Gemcitabine—breast cancer	2.26e-05	0.000128	CcSEcCtD
Bicalutamide—Dermatitis—Gemcitabine—breast cancer	2.26e-05	0.000128	CcSEcCtD
Bicalutamide—Malnutrition—Methotrexate—breast cancer	2.24e-05	0.000127	CcSEcCtD
Bicalutamide—Haemoglobin—Doxorubicin—breast cancer	2.24e-05	0.000127	CcSEcCtD
Bicalutamide—Headache—Gemcitabine—breast cancer	2.24e-05	0.000127	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Capecitabine—breast cancer	2.24e-05	0.000127	CcSEcCtD
Bicalutamide—Cardiac disorder—Epirubicin—breast cancer	2.24e-05	0.000127	CcSEcCtD
Bicalutamide—Vomiting—Fluorouracil—breast cancer	2.24e-05	0.000127	CcSEcCtD
Bicalutamide—Rhinitis—Doxorubicin—breast cancer	2.24e-05	0.000127	CcSEcCtD
Bicalutamide—Dyspepsia—Docetaxel—breast cancer	2.24e-05	0.000127	CcSEcCtD
Bicalutamide—Haemorrhage—Doxorubicin—breast cancer	2.23e-05	0.000127	CcSEcCtD
Bicalutamide—Insomnia—Capecitabine—breast cancer	2.23e-05	0.000126	CcSEcCtD
Bicalutamide—Rash—Fluorouracil—breast cancer	2.22e-05	0.000126	CcSEcCtD
Bicalutamide—Dermatitis—Fluorouracil—breast cancer	2.22e-05	0.000126	CcSEcCtD
Bicalutamide—Pharyngitis—Doxorubicin—breast cancer	2.22e-05	0.000126	CcSEcCtD
Bicalutamide—Paraesthesia—Capecitabine—breast cancer	2.21e-05	0.000125	CcSEcCtD
Bicalutamide—Decreased appetite—Docetaxel—breast cancer	2.21e-05	0.000125	CcSEcCtD
Bicalutamide—Hypersensitivity—Paclitaxel—breast cancer	2.21e-05	0.000125	CcSEcCtD
Bicalutamide—Headache—Fluorouracil—breast cancer	2.21e-05	0.000125	CcSEcCtD
Bicalutamide—Urinary tract disorder—Doxorubicin—breast cancer	2.2e-05	0.000125	CcSEcCtD
Bicalutamide—Oedema peripheral—Doxorubicin—breast cancer	2.2e-05	0.000125	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Docetaxel—breast cancer	2.19e-05	0.000124	CcSEcCtD
Bicalutamide—Dyspnoea—Capecitabine—breast cancer	2.19e-05	0.000124	CcSEcCtD
Bicalutamide—Fatigue—Docetaxel—breast cancer	2.19e-05	0.000124	CcSEcCtD
Bicalutamide—Angiopathy—Epirubicin—breast cancer	2.19e-05	0.000124	CcSEcCtD
Bicalutamide—Urethral disorder—Doxorubicin—breast cancer	2.19e-05	0.000124	CcSEcCtD
Bicalutamide—Nausea—Irinotecan—breast cancer	2.18e-05	0.000124	CcSEcCtD
Bicalutamide—Nausea—Mitoxantrone—breast cancer	2.18e-05	0.000124	CcSEcCtD
Bicalutamide—Immune system disorder—Epirubicin—breast cancer	2.18e-05	0.000124	CcSEcCtD
Bicalutamide—Mediastinal disorder—Epirubicin—breast cancer	2.17e-05	0.000123	CcSEcCtD
Bicalutamide—Pain—Docetaxel—breast cancer	2.17e-05	0.000123	CcSEcCtD
Bicalutamide—Constipation—Docetaxel—breast cancer	2.17e-05	0.000123	CcSEcCtD
Bicalutamide—Back pain—Methotrexate—breast cancer	2.17e-05	0.000123	CcSEcCtD
Bicalutamide—Dyspepsia—Capecitabine—breast cancer	2.17e-05	0.000123	CcSEcCtD
Bicalutamide—Chills—Epirubicin—breast cancer	2.17e-05	0.000123	CcSEcCtD
Bicalutamide—Arrhythmia—Epirubicin—breast cancer	2.16e-05	0.000122	CcSEcCtD
Bicalutamide—Visual impairment—Doxorubicin—breast cancer	2.15e-05	0.000122	CcSEcCtD
Bicalutamide—Asthenia—Paclitaxel—breast cancer	2.15e-05	0.000122	CcSEcCtD
Bicalutamide—Decreased appetite—Capecitabine—breast cancer	2.14e-05	0.000121	CcSEcCtD
Bicalutamide—Alopecia—Epirubicin—breast cancer	2.13e-05	0.000121	CcSEcCtD
Bicalutamide—Nausea—Gemcitabine—breast cancer	2.13e-05	0.000121	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Capecitabine—breast cancer	2.12e-05	0.00012	CcSEcCtD
Bicalutamide—Fatigue—Capecitabine—breast cancer	2.12e-05	0.00012	CcSEcCtD
Bicalutamide—Pruritus—Paclitaxel—breast cancer	2.12e-05	0.00012	CcSEcCtD
Bicalutamide—Mental disorder—Epirubicin—breast cancer	2.11e-05	0.00012	CcSEcCtD
Bicalutamide—Constipation—Capecitabine—breast cancer	2.1e-05	0.000119	CcSEcCtD
Bicalutamide—Pain—Capecitabine—breast cancer	2.1e-05	0.000119	CcSEcCtD
Bicalutamide—Malnutrition—Epirubicin—breast cancer	2.1e-05	0.000119	CcSEcCtD
Bicalutamide—Feeling abnormal—Docetaxel—breast cancer	2.09e-05	0.000119	CcSEcCtD
Bicalutamide—Nausea—Fluorouracil—breast cancer	2.09e-05	0.000119	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Docetaxel—breast cancer	2.08e-05	0.000118	CcSEcCtD
Bicalutamide—Anaemia—Methotrexate—breast cancer	2.07e-05	0.000118	CcSEcCtD
Bicalutamide—Cardiac disorder—Doxorubicin—breast cancer	2.07e-05	0.000117	CcSEcCtD
Bicalutamide—Flatulence—Epirubicin—breast cancer	2.07e-05	0.000117	CcSEcCtD
Bicalutamide—Tension—Epirubicin—breast cancer	2.06e-05	0.000117	CcSEcCtD
Bicalutamide—Diarrhoea—Paclitaxel—breast cancer	2.05e-05	0.000116	CcSEcCtD
Bicalutamide—Nervousness—Epirubicin—breast cancer	2.04e-05	0.000116	CcSEcCtD
Bicalutamide—Back pain—Epirubicin—breast cancer	2.03e-05	0.000115	CcSEcCtD
Bicalutamide—Feeling abnormal—Capecitabine—breast cancer	2.03e-05	0.000115	CcSEcCtD
Bicalutamide—Angiopathy—Doxorubicin—breast cancer	2.03e-05	0.000115	CcSEcCtD
Bicalutamide—Muscle spasms—Epirubicin—breast cancer	2.02e-05	0.000114	CcSEcCtD
Bicalutamide—Immune system disorder—Doxorubicin—breast cancer	2.02e-05	0.000114	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Capecitabine—breast cancer	2.01e-05	0.000114	CcSEcCtD
Bicalutamide—Mediastinal disorder—Doxorubicin—breast cancer	2.01e-05	0.000114	CcSEcCtD
Bicalutamide—Abdominal pain—Docetaxel—breast cancer	2.01e-05	0.000114	CcSEcCtD
Bicalutamide—Body temperature increased—Docetaxel—breast cancer	2.01e-05	0.000114	CcSEcCtD
Bicalutamide—Chills—Doxorubicin—breast cancer	2e-05	0.000114	CcSEcCtD
Bicalutamide—Arrhythmia—Doxorubicin—breast cancer	1.99e-05	0.000113	CcSEcCtD
Bicalutamide—Dizziness—Paclitaxel—breast cancer	1.98e-05	0.000112	CcSEcCtD
Bicalutamide—Alopecia—Doxorubicin—breast cancer	1.97e-05	0.000112	CcSEcCtD
Bicalutamide—Cough—Methotrexate—breast cancer	1.96e-05	0.000111	CcSEcCtD
Bicalutamide—Mental disorder—Doxorubicin—breast cancer	1.96e-05	0.000111	CcSEcCtD
Bicalutamide—Urticaria—Capecitabine—breast cancer	1.95e-05	0.000111	CcSEcCtD
Bicalutamide—Abdominal pain—Capecitabine—breast cancer	1.95e-05	0.00011	CcSEcCtD
Bicalutamide—Body temperature increased—Capecitabine—breast cancer	1.95e-05	0.00011	CcSEcCtD
Bicalutamide—Malnutrition—Doxorubicin—breast cancer	1.94e-05	0.00011	CcSEcCtD
Bicalutamide—Anaemia—Epirubicin—breast cancer	1.94e-05	0.00011	CcSEcCtD
Bicalutamide—Flatulence—Doxorubicin—breast cancer	1.92e-05	0.000109	CcSEcCtD
Bicalutamide—Chest pain—Methotrexate—breast cancer	1.91e-05	0.000108	CcSEcCtD
Bicalutamide—Myalgia—Methotrexate—breast cancer	1.91e-05	0.000108	CcSEcCtD
Bicalutamide—Tension—Doxorubicin—breast cancer	1.91e-05	0.000108	CcSEcCtD
Bicalutamide—Vomiting—Paclitaxel—breast cancer	1.91e-05	0.000108	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.9e-05	0.000108	CcSEcCtD
Bicalutamide—Rash—Paclitaxel—breast cancer	1.89e-05	0.000107	CcSEcCtD
Bicalutamide—Dermatitis—Paclitaxel—breast cancer	1.89e-05	0.000107	CcSEcCtD
Bicalutamide—Nervousness—Doxorubicin—breast cancer	1.89e-05	0.000107	CcSEcCtD
Bicalutamide—Syncope—Epirubicin—breast cancer	1.88e-05	0.000107	CcSEcCtD
Bicalutamide—Back pain—Doxorubicin—breast cancer	1.88e-05	0.000107	CcSEcCtD
Bicalutamide—Headache—Paclitaxel—breast cancer	1.88e-05	0.000106	CcSEcCtD
Bicalutamide—Hypersensitivity—Docetaxel—breast cancer	1.87e-05	0.000106	CcSEcCtD
Bicalutamide—Muscle spasms—Doxorubicin—breast cancer	1.87e-05	0.000106	CcSEcCtD
Bicalutamide—Confusional state—Methotrexate—breast cancer	1.85e-05	0.000105	CcSEcCtD
Bicalutamide—Loss of consciousness—Epirubicin—breast cancer	1.85e-05	0.000105	CcSEcCtD
Bicalutamide—Cough—Epirubicin—breast cancer	1.83e-05	0.000104	CcSEcCtD
Bicalutamide—Asthenia—Docetaxel—breast cancer	1.82e-05	0.000103	CcSEcCtD
Bicalutamide—Infection—Methotrexate—breast cancer	1.82e-05	0.000103	CcSEcCtD
Bicalutamide—Hypertension—Epirubicin—breast cancer	1.81e-05	0.000103	CcSEcCtD
Bicalutamide—Hypersensitivity—Capecitabine—breast cancer	1.81e-05	0.000103	CcSEcCtD
Bicalutamide—Pruritus—Docetaxel—breast cancer	1.8e-05	0.000102	CcSEcCtD
Bicalutamide—Nervous system disorder—Methotrexate—breast cancer	1.8e-05	0.000102	CcSEcCtD
Bicalutamide—Anaemia—Doxorubicin—breast cancer	1.8e-05	0.000102	CcSEcCtD
Bicalutamide—Thrombocytopenia—Methotrexate—breast cancer	1.79e-05	0.000102	CcSEcCtD
Bicalutamide—Myalgia—Epirubicin—breast cancer	1.79e-05	0.000101	CcSEcCtD
Bicalutamide—Chest pain—Epirubicin—breast cancer	1.79e-05	0.000101	CcSEcCtD
Bicalutamide—Anxiety—Epirubicin—breast cancer	1.78e-05	0.000101	CcSEcCtD
Bicalutamide—Nausea—Paclitaxel—breast cancer	1.78e-05	0.000101	CcSEcCtD
Bicalutamide—Skin disorder—Methotrexate—breast cancer	1.78e-05	0.000101	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.78e-05	0.000101	CcSEcCtD
Bicalutamide—Hyperhidrosis—Methotrexate—breast cancer	1.77e-05	0.0001	CcSEcCtD
Bicalutamide—Asthenia—Capecitabine—breast cancer	1.77e-05	0.0001	CcSEcCtD
Bicalutamide—Dry mouth—Epirubicin—breast cancer	1.75e-05	9.91e-05	CcSEcCtD
Bicalutamide—Anorexia—Methotrexate—breast cancer	1.75e-05	9.9e-05	CcSEcCtD
Bicalutamide—Syncope—Doxorubicin—breast cancer	1.74e-05	9.88e-05	CcSEcCtD
Bicalutamide—Pruritus—Capecitabine—breast cancer	1.74e-05	9.87e-05	CcSEcCtD
Bicalutamide—Diarrhoea—Docetaxel—breast cancer	1.74e-05	9.86e-05	CcSEcCtD
Bicalutamide—Confusional state—Epirubicin—breast cancer	1.73e-05	9.8e-05	CcSEcCtD
Bicalutamide—Oedema—Epirubicin—breast cancer	1.71e-05	9.72e-05	CcSEcCtD
Bicalutamide—Loss of consciousness—Doxorubicin—breast cancer	1.71e-05	9.68e-05	CcSEcCtD
Bicalutamide—Infection—Epirubicin—breast cancer	1.7e-05	9.65e-05	CcSEcCtD
Bicalutamide—Cough—Doxorubicin—breast cancer	1.7e-05	9.61e-05	CcSEcCtD
Bicalutamide—Shock—Epirubicin—breast cancer	1.69e-05	9.56e-05	CcSEcCtD
Bicalutamide—Diarrhoea—Capecitabine—breast cancer	1.68e-05	9.54e-05	CcSEcCtD
Bicalutamide—Nervous system disorder—Epirubicin—breast cancer	1.68e-05	9.53e-05	CcSEcCtD
Bicalutamide—Dizziness—Docetaxel—breast cancer	1.68e-05	9.53e-05	CcSEcCtD
Bicalutamide—Thrombocytopenia—Epirubicin—breast cancer	1.68e-05	9.51e-05	CcSEcCtD
Bicalutamide—Hypertension—Doxorubicin—breast cancer	1.68e-05	9.51e-05	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Methotrexate—breast cancer	1.67e-05	9.46e-05	CcSEcCtD
Bicalutamide—Skin disorder—Epirubicin—breast cancer	1.67e-05	9.44e-05	CcSEcCtD
Bicalutamide—Hyperhidrosis—Epirubicin—breast cancer	1.66e-05	9.39e-05	CcSEcCtD
Bicalutamide—Insomnia—Methotrexate—breast cancer	1.66e-05	9.39e-05	CcSEcCtD
Bicalutamide—Chest pain—Doxorubicin—breast cancer	1.65e-05	9.38e-05	CcSEcCtD
Bicalutamide—Myalgia—Doxorubicin—breast cancer	1.65e-05	9.38e-05	CcSEcCtD
Bicalutamide—Anxiety—Doxorubicin—breast cancer	1.65e-05	9.35e-05	CcSEcCtD
Bicalutamide—Paraesthesia—Methotrexate—breast cancer	1.64e-05	9.32e-05	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.64e-05	9.31e-05	CcSEcCtD
Bicalutamide—Anorexia—Epirubicin—breast cancer	1.63e-05	9.26e-05	CcSEcCtD
Bicalutamide—Dyspnoea—Methotrexate—breast cancer	1.63e-05	9.26e-05	CcSEcCtD
Bicalutamide—Somnolence—Methotrexate—breast cancer	1.63e-05	9.23e-05	CcSEcCtD
Bicalutamide—Dizziness—Capecitabine—breast cancer	1.63e-05	9.22e-05	CcSEcCtD
Bicalutamide—Dry mouth—Doxorubicin—breast cancer	1.62e-05	9.17e-05	CcSEcCtD
Bicalutamide—Vomiting—Docetaxel—breast cancer	1.62e-05	9.16e-05	CcSEcCtD
Bicalutamide—Dyspepsia—Methotrexate—breast cancer	1.61e-05	9.14e-05	CcSEcCtD
Bicalutamide—Rash—Docetaxel—breast cancer	1.6e-05	9.08e-05	CcSEcCtD
Bicalutamide—Dermatitis—Docetaxel—breast cancer	1.6e-05	9.07e-05	CcSEcCtD
Bicalutamide—Confusional state—Doxorubicin—breast cancer	1.6e-05	9.07e-05	CcSEcCtD
Bicalutamide—Decreased appetite—Methotrexate—breast cancer	1.59e-05	9.03e-05	CcSEcCtD
Bicalutamide—Headache—Docetaxel—breast cancer	1.59e-05	9.02e-05	CcSEcCtD
Bicalutamide—Oedema—Doxorubicin—breast cancer	1.59e-05	8.99e-05	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Methotrexate—breast cancer	1.58e-05	8.96e-05	CcSEcCtD
Bicalutamide—Fatigue—Methotrexate—breast cancer	1.58e-05	8.95e-05	CcSEcCtD
Bicalutamide—Infection—Doxorubicin—breast cancer	1.58e-05	8.93e-05	CcSEcCtD
Bicalutamide—Pain—Methotrexate—breast cancer	1.57e-05	8.88e-05	CcSEcCtD
Bicalutamide—Vomiting—Capecitabine—breast cancer	1.56e-05	8.87e-05	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Epirubicin—breast cancer	1.56e-05	8.85e-05	CcSEcCtD
Bicalutamide—Shock—Doxorubicin—breast cancer	1.56e-05	8.85e-05	CcSEcCtD
Bicalutamide—Nervous system disorder—Doxorubicin—breast cancer	1.56e-05	8.82e-05	CcSEcCtD
Bicalutamide—Thrombocytopenia—Doxorubicin—breast cancer	1.55e-05	8.8e-05	CcSEcCtD
Bicalutamide—Rash—Capecitabine—breast cancer	1.55e-05	8.79e-05	CcSEcCtD
Bicalutamide—Insomnia—Epirubicin—breast cancer	1.55e-05	8.79e-05	CcSEcCtD
Bicalutamide—Dermatitis—Capecitabine—breast cancer	1.55e-05	8.79e-05	CcSEcCtD
Bicalutamide—Headache—Capecitabine—breast cancer	1.54e-05	8.74e-05	CcSEcCtD
Bicalutamide—Skin disorder—Doxorubicin—breast cancer	1.54e-05	8.73e-05	CcSEcCtD
Bicalutamide—Paraesthesia—Epirubicin—breast cancer	1.54e-05	8.73e-05	CcSEcCtD
Bicalutamide—Hyperhidrosis—Doxorubicin—breast cancer	1.53e-05	8.69e-05	CcSEcCtD
Bicalutamide—Dyspnoea—Epirubicin—breast cancer	1.53e-05	8.66e-05	CcSEcCtD
Bicalutamide—Somnolence—Epirubicin—breast cancer	1.52e-05	8.64e-05	CcSEcCtD
Bicalutamide—Anorexia—Doxorubicin—breast cancer	1.51e-05	8.57e-05	CcSEcCtD
Bicalutamide—Nausea—Docetaxel—breast cancer	1.51e-05	8.56e-05	CcSEcCtD
Bicalutamide—Feeling abnormal—Methotrexate—breast cancer	1.51e-05	8.56e-05	CcSEcCtD
Bicalutamide—Dyspepsia—Epirubicin—breast cancer	1.51e-05	8.55e-05	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Methotrexate—breast cancer	1.5e-05	8.49e-05	CcSEcCtD
Bicalutamide—Decreased appetite—Epirubicin—breast cancer	1.49e-05	8.45e-05	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Epirubicin—breast cancer	1.48e-05	8.39e-05	CcSEcCtD
Bicalutamide—Fatigue—Epirubicin—breast cancer	1.48e-05	8.38e-05	CcSEcCtD
Bicalutamide—Constipation—Epirubicin—breast cancer	1.47e-05	8.31e-05	CcSEcCtD
Bicalutamide—Pain—Epirubicin—breast cancer	1.47e-05	8.31e-05	CcSEcCtD
Bicalutamide—Nausea—Capecitabine—breast cancer	1.46e-05	8.28e-05	CcSEcCtD
Bicalutamide—Urticaria—Methotrexate—breast cancer	1.46e-05	8.25e-05	CcSEcCtD
Bicalutamide—Body temperature increased—Methotrexate—breast cancer	1.45e-05	8.21e-05	CcSEcCtD
Bicalutamide—Abdominal pain—Methotrexate—breast cancer	1.45e-05	8.21e-05	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.45e-05	8.19e-05	CcSEcCtD
Bicalutamide—Insomnia—Doxorubicin—breast cancer	1.43e-05	8.13e-05	CcSEcCtD
Bicalutamide—Paraesthesia—Doxorubicin—breast cancer	1.42e-05	8.07e-05	CcSEcCtD
Bicalutamide—Dyspnoea—Doxorubicin—breast cancer	1.41e-05	8.02e-05	CcSEcCtD
Bicalutamide—Feeling abnormal—Epirubicin—breast cancer	1.41e-05	8.01e-05	CcSEcCtD
Bicalutamide—Somnolence—Doxorubicin—breast cancer	1.41e-05	7.99e-05	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Epirubicin—breast cancer	1.4e-05	7.95e-05	CcSEcCtD
Bicalutamide—Dyspepsia—Doxorubicin—breast cancer	1.4e-05	7.91e-05	CcSEcCtD
Bicalutamide—Decreased appetite—Doxorubicin—breast cancer	1.38e-05	7.82e-05	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Doxorubicin—breast cancer	1.37e-05	7.76e-05	CcSEcCtD
Bicalutamide—Fatigue—Doxorubicin—breast cancer	1.37e-05	7.75e-05	CcSEcCtD
Bicalutamide—Urticaria—Epirubicin—breast cancer	1.36e-05	7.72e-05	CcSEcCtD
Bicalutamide—Pain—Doxorubicin—breast cancer	1.36e-05	7.69e-05	CcSEcCtD
Bicalutamide—Constipation—Doxorubicin—breast cancer	1.36e-05	7.69e-05	CcSEcCtD
Bicalutamide—Body temperature increased—Epirubicin—breast cancer	1.36e-05	7.68e-05	CcSEcCtD
Bicalutamide—Abdominal pain—Epirubicin—breast cancer	1.36e-05	7.68e-05	CcSEcCtD
Bicalutamide—Hypersensitivity—Methotrexate—breast cancer	1.35e-05	7.65e-05	CcSEcCtD
Bicalutamide—Asthenia—Methotrexate—breast cancer	1.31e-05	7.45e-05	CcSEcCtD
Bicalutamide—Feeling abnormal—Doxorubicin—breast cancer	1.31e-05	7.41e-05	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Doxorubicin—breast cancer	1.3e-05	7.35e-05	CcSEcCtD
Bicalutamide—Pruritus—Methotrexate—breast cancer	1.3e-05	7.35e-05	CcSEcCtD
Bicalutamide—Hypersensitivity—Epirubicin—breast cancer	1.26e-05	7.16e-05	CcSEcCtD
Bicalutamide—Urticaria—Doxorubicin—breast cancer	1.26e-05	7.14e-05	CcSEcCtD
Bicalutamide—Abdominal pain—Doxorubicin—breast cancer	1.25e-05	7.11e-05	CcSEcCtD
Bicalutamide—Body temperature increased—Doxorubicin—breast cancer	1.25e-05	7.11e-05	CcSEcCtD
Bicalutamide—Diarrhoea—Methotrexate—breast cancer	1.25e-05	7.1e-05	CcSEcCtD
Bicalutamide—Asthenia—Epirubicin—breast cancer	1.23e-05	6.97e-05	CcSEcCtD
Bicalutamide—Pruritus—Epirubicin—breast cancer	1.21e-05	6.87e-05	CcSEcCtD
Bicalutamide—Dizziness—Methotrexate—breast cancer	1.21e-05	6.87e-05	CcSEcCtD
Bicalutamide—Diarrhoea—Epirubicin—breast cancer	1.17e-05	6.65e-05	CcSEcCtD
Bicalutamide—Hypersensitivity—Doxorubicin—breast cancer	1.17e-05	6.62e-05	CcSEcCtD
Bicalutamide—Vomiting—Methotrexate—breast cancer	1.16e-05	6.6e-05	CcSEcCtD
Bicalutamide—Rash—Methotrexate—breast cancer	1.16e-05	6.55e-05	CcSEcCtD
Bicalutamide—Dermatitis—Methotrexate—breast cancer	1.15e-05	6.54e-05	CcSEcCtD
Bicalutamide—Headache—Methotrexate—breast cancer	1.15e-05	6.5e-05	CcSEcCtD
Bicalutamide—Asthenia—Doxorubicin—breast cancer	1.14e-05	6.45e-05	CcSEcCtD
Bicalutamide—Dizziness—Epirubicin—breast cancer	1.13e-05	6.43e-05	CcSEcCtD
Bicalutamide—Pruritus—Doxorubicin—breast cancer	1.12e-05	6.36e-05	CcSEcCtD
Bicalutamide—Vomiting—Epirubicin—breast cancer	1.09e-05	6.18e-05	CcSEcCtD
Bicalutamide—Nausea—Methotrexate—breast cancer	1.09e-05	6.17e-05	CcSEcCtD
Bicalutamide—Diarrhoea—Doxorubicin—breast cancer	1.09e-05	6.15e-05	CcSEcCtD
Bicalutamide—Rash—Epirubicin—breast cancer	1.08e-05	6.13e-05	CcSEcCtD
Bicalutamide—Dermatitis—Epirubicin—breast cancer	1.08e-05	6.12e-05	CcSEcCtD
Bicalutamide—Headache—Epirubicin—breast cancer	1.07e-05	6.09e-05	CcSEcCtD
Bicalutamide—Dizziness—Doxorubicin—breast cancer	1.05e-05	5.95e-05	CcSEcCtD
Bicalutamide—Nausea—Epirubicin—breast cancer	1.02e-05	5.77e-05	CcSEcCtD
Bicalutamide—Vomiting—Doxorubicin—breast cancer	1.01e-05	5.72e-05	CcSEcCtD
Bicalutamide—Rash—Doxorubicin—breast cancer	1e-05	5.67e-05	CcSEcCtD
Bicalutamide—Dermatitis—Doxorubicin—breast cancer	9.99e-06	5.66e-05	CcSEcCtD
Bicalutamide—Headache—Doxorubicin—breast cancer	9.94e-06	5.63e-05	CcSEcCtD
Bicalutamide—Nausea—Doxorubicin—breast cancer	9.42e-06	5.34e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—NAT2—breast cancer	6.29e-06	0.000102	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NAT2—breast cancer	6.23e-06	0.000101	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	6.18e-06	0.0001	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ANGPTL4—breast cancer	6e-06	9.73e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ESRRA—breast cancer	6e-06	9.73e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MED12—breast cancer	6e-06	9.73e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—DPYD—breast cancer	6e-06	9.73e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALDOA—breast cancer	5.9e-06	9.58e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NCOA3—breast cancer	5.73e-06	9.3e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC2A2—breast cancer	5.69e-06	9.23e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GPI—breast cancer	5.69e-06	9.23e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HADHB—breast cancer	5.69e-06	9.23e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	5.64e-06	9.15e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	5.63e-06	9.14e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CPT1A—breast cancer	5.57e-06	9.04e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTR—breast cancer	5.57e-06	9.04e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCG2—breast cancer	5.57e-06	9.04e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—DPYD—breast cancer	5.51e-06	8.95e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MED12—breast cancer	5.51e-06	8.95e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MED12—breast cancer	5.47e-06	8.87e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—DPYD—breast cancer	5.47e-06	8.87e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HPGDS—breast cancer	5.47e-06	8.87e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HBA1—breast cancer	5.43e-06	8.81e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALDOA—breast cancer	5.43e-06	8.81e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALDH1A1—breast cancer	5.43e-06	8.8e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALDH7A1—breast cancer	5.43e-06	8.8e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALDOA—breast cancer	5.38e-06	8.73e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTT1—breast cancer	5.3e-06	8.6e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ACHE—breast cancer	5.3e-06	8.6e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NCOA3—breast cancer	5.27e-06	8.55e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC2A2—breast cancer	5.23e-06	8.49e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NCOA3—breast cancer	5.22e-06	8.48e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PHGDH—breast cancer	5.2e-06	8.44e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NME1—breast cancer	5.2e-06	8.44e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—UMPS—breast cancer	5.2e-06	8.44e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—FHL2—breast cancer	5.2e-06	8.44e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADSL—breast cancer	5.2e-06	8.44e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC2A2—breast cancer	5.19e-06	8.42e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	5.13e-06	8.33e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CPT1A—breast cancer	5.13e-06	8.32e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTR—breast cancer	5.13e-06	8.32e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCG2—breast cancer	5.13e-06	8.32e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LDHB—breast cancer	5.1e-06	8.28e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—BRIP1—breast cancer	5.1e-06	8.28e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HPSE—breast cancer	5.1e-06	8.28e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCG2—breast cancer	5.08e-06	8.25e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTR—breast cancer	5.08e-06	8.25e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CPT1A—breast cancer	5.08e-06	8.25e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HPGDS—breast cancer	5.03e-06	8.16e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP17A1—breast cancer	5.02e-06	8.14e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HBA1—breast cancer	5e-06	8.11e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HPGDS—breast cancer	4.98e-06	8.09e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ENO1—breast cancer	4.97e-06	8.06e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS1—breast cancer	4.97e-06	8.06e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HBA1—breast cancer	4.95e-06	8.04e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.95e-06	8.03e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.89e-06	7.93e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ACHE—breast cancer	4.88e-06	7.91e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTT1—breast cancer	4.88e-06	7.91e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2D6—breast cancer	4.87e-06	7.91e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCC1—breast cancer	4.84e-06	7.85e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA3—breast cancer	4.84e-06	7.85e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMMR—breast cancer	4.84e-06	7.85e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTT1—breast cancer	4.83e-06	7.84e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ACHE—breast cancer	4.83e-06	7.84e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NCOA2—breast cancer	4.78e-06	7.76e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.68e-06	7.6e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—FASN—breast cancer	4.64e-06	7.53e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—BCHE—breast cancer	4.62e-06	7.49e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP17A1—breast cancer	4.62e-06	7.49e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP17A1—breast cancer	4.58e-06	7.43e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ENO1—breast cancer	4.57e-06	7.41e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS1—breast cancer	4.57e-06	7.41e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC5A5—breast cancer	4.56e-06	7.4e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS1—breast cancer	4.53e-06	7.35e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ENO1—breast cancer	4.53e-06	7.35e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.51e-06	7.32e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.46e-06	7.23e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2D6—breast cancer	4.44e-06	7.21e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CA9—breast cancer	4.42e-06	7.18e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA4—breast cancer	4.42e-06	7.18e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC2A1—breast cancer	4.41e-06	7.15e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NQO1—breast cancer	4.41e-06	7.15e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NCOA2—breast cancer	4.4e-06	7.14e-05	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MAPK3—breast cancer	4.37e-06	7.09e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NCOA2—breast cancer	4.36e-06	7.08e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.31e-06	7e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA2—breast cancer	4.31e-06	6.99e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GPX2—breast cancer	4.31e-06	6.99e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP3A4—breast cancer	4.3e-06	6.97e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.28e-06	6.94e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—FASN—breast cancer	4.27e-06	6.92e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SULT1A1—breast cancer	4.26e-06	6.91e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GPX4—breast cancer	4.26e-06	6.91e-05	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MYC—breast cancer	4.25e-06	6.9e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—BCHE—breast cancer	4.25e-06	6.89e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—FASN—breast cancer	4.23e-06	6.86e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP1B1—breast cancer	4.22e-06	6.85e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—BCHE—breast cancer	4.21e-06	6.83e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC5A5—breast cancer	4.2e-06	6.81e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC5A5—breast cancer	4.16e-06	6.75e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA1—breast cancer	4.16e-06	6.75e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—IDH1—breast cancer	4.16e-06	6.75e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HSP90AA1—breast cancer	4.14e-06	6.72e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NAT2—breast cancer	4.11e-06	6.67e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NQO1—breast cancer	4.05e-06	6.58e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC2A1—breast cancer	4.05e-06	6.58e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NCOA1—breast cancer	4.03e-06	6.54e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC2A1—breast cancer	4.02e-06	6.52e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NQO1—breast cancer	4.02e-06	6.52e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—STK11—breast cancer	3.97e-06	6.44e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP19A1—breast cancer	3.97e-06	6.44e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP3A4—breast cancer	3.95e-06	6.41e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.93e-06	6.38e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP3A4—breast cancer	3.92e-06	6.36e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.9e-06	6.32e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP1B1—breast cancer	3.89e-06	6.3e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP1B1—breast cancer	3.85e-06	6.25e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.81e-06	6.18e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.78e-06	6.13e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.73e-06	6.05e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NCOA1—breast cancer	3.71e-06	6.01e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—COMT—breast cancer	3.69e-06	5.99e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTP1—breast cancer	3.68e-06	5.96e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NCOA1—breast cancer	3.67e-06	5.96e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—STK11—breast cancer	3.65e-06	5.93e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP19A1—breast cancer	3.65e-06	5.93e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HMOX1—breast cancer	3.62e-06	5.88e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—STK11—breast cancer	3.62e-06	5.88e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP19A1—breast cancer	3.62e-06	5.88e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ITPR1—breast cancer	3.62e-06	5.87e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MED12—breast cancer	3.61e-06	5.85e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—DPYD—breast cancer	3.61e-06	5.85e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALDOA—breast cancer	3.55e-06	5.76e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCB1—breast cancer	3.48e-06	5.64e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NCOA3—breast cancer	3.45e-06	5.59e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC2A2—breast cancer	3.42e-06	5.55e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—TYMS—breast cancer	3.42e-06	5.54e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.4e-06	5.52e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—COMT—breast cancer	3.4e-06	5.51e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTP1—breast cancer	3.38e-06	5.48e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTM1—breast cancer	3.38e-06	5.48e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NCOR1—breast cancer	3.38e-06	5.48e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.38e-06	5.48e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—COMT—breast cancer	3.37e-06	5.46e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTR—breast cancer	3.35e-06	5.44e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCG2—breast cancer	3.35e-06	5.44e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CPT1A—breast cancer	3.35e-06	5.44e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTP1—breast cancer	3.35e-06	5.44e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HMOX1—breast cancer	3.33e-06	5.41e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ITPR1—breast cancer	3.33e-06	5.4e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HMOX1—breast cancer	3.3e-06	5.36e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ITPR1—breast cancer	3.3e-06	5.35e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HPGDS—breast cancer	3.29e-06	5.33e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HBA1—breast cancer	3.27e-06	5.3e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GPX1—breast cancer	3.23e-06	5.25e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP1A1—breast cancer	3.2e-06	5.19e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCB1—breast cancer	3.2e-06	5.19e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ACHE—breast cancer	3.19e-06	5.17e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTT1—breast cancer	3.19e-06	5.17e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ERCC2—breast cancer	3.18e-06	5.15e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCB1—breast cancer	3.17e-06	5.15e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—TYMS—breast cancer	3.14e-06	5.1e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—TYMS—breast cancer	3.12e-06	5.05e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTM1—breast cancer	3.11e-06	5.04e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.11e-06	5.04e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NCOR1—breast cancer	3.11e-06	5.04e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NCOR1—breast cancer	3.08e-06	5e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.08e-06	5e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTM1—breast cancer	3.08e-06	5e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP17A1—breast cancer	3.02e-06	4.9e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS1—breast cancer	2.99e-06	4.85e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ENO1—breast cancer	2.99e-06	4.85e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTHFR—breast cancer	2.98e-06	4.84e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GPX1—breast cancer	2.97e-06	4.83e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GPX1—breast cancer	2.95e-06	4.78e-05	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—AKT1—breast cancer	2.95e-06	4.78e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP1A1—breast cancer	2.94e-06	4.78e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2D6—breast cancer	2.93e-06	4.75e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ERCC2—breast cancer	2.92e-06	4.74e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP1A1—breast cancer	2.92e-06	4.74e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ERCC2—breast cancer	2.9e-06	4.7e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NCOA2—breast cancer	2.88e-06	4.67e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—FASN—breast cancer	2.79e-06	4.53e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—BCHE—breast cancer	2.78e-06	4.51e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CAV1—breast cancer	2.75e-06	4.47e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTHFR—breast cancer	2.75e-06	4.45e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC5A5—breast cancer	2.74e-06	4.45e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTHFR—breast cancer	2.72e-06	4.42e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NQO1—breast cancer	2.65e-06	4.3e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC2A1—breast cancer	2.65e-06	4.3e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.63e-06	4.27e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP1B1—breast cancer	2.54e-06	4.12e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CAV1—breast cancer	2.53e-06	4.11e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CAV1—breast cancer	2.51e-06	4.07e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CG—breast cancer	2.51e-06	4.07e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.49e-06	4.04e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NCOA1—breast cancer	2.42e-06	3.93e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.4e-06	3.89e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—STK11—breast cancer	2.39e-06	3.88e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP19A1—breast cancer	2.39e-06	3.88e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CG—breast cancer	2.31e-06	3.74e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CG—breast cancer	2.29e-06	3.71e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—COMT—breast cancer	2.22e-06	3.6e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTP1—breast cancer	2.21e-06	3.59e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CD—breast cancer	2.2e-06	3.58e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMOX1—breast cancer	2.18e-06	3.54e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALB—breast cancer	2.18e-06	3.53e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ITPR1—breast cancer	2.17e-06	3.53e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCB1—breast cancer	2.09e-06	3.39e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NOS3—breast cancer	2.08e-06	3.38e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—TYMS—breast cancer	2.05e-06	3.33e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.03e-06	3.3e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NCOR1—breast cancer	2.03e-06	3.3e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTM1—breast cancer	2.03e-06	3.3e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CD—breast cancer	2.03e-06	3.29e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CD—breast cancer	2.01e-06	3.26e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALB—breast cancer	2e-06	3.25e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALB—breast cancer	1.98e-06	3.22e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GPX1—breast cancer	1.94e-06	3.16e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP1A1—breast cancer	1.93e-06	3.12e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CB—breast cancer	1.92e-06	3.12e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NOS3—breast cancer	1.91e-06	3.11e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ERCC2—breast cancer	1.91e-06	3.1e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS2—breast cancer	1.9e-06	3.09e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NOS3—breast cancer	1.9e-06	3.08e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTHFR—breast cancer	1.79e-06	2.91e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CB—breast cancer	1.77e-06	2.87e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CB—breast cancer	1.75e-06	2.84e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS2—breast cancer	1.75e-06	2.84e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS2—breast cancer	1.74e-06	2.82e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTEN—breast cancer	1.66e-06	2.69e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CAV1—breast cancer	1.66e-06	2.69e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTEN—breast cancer	1.53e-06	2.48e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTEN—breast cancer	1.51e-06	2.46e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CG—breast cancer	1.51e-06	2.45e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CD—breast cancer	1.33e-06	2.15e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALB—breast cancer	1.31e-06	2.12e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NOS3—breast cancer	1.25e-06	2.03e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CA—breast cancer	1.17e-06	1.9e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CB—breast cancer	1.16e-06	1.87e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS2—breast cancer	1.14e-06	1.86e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CA—breast cancer	1.08e-06	1.75e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CA—breast cancer	1.07e-06	1.73e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTEN—breast cancer	9.98e-07	1.62e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AKT1—breast cancer	9.57e-07	1.55e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AKT1—breast cancer	8.8e-07	1.43e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AKT1—breast cancer	8.73e-07	1.42e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CA—breast cancer	7.04e-07	1.14e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AKT1—breast cancer	5.75e-07	9.34e-06	CbGpPWpGaD
